Inclusion Criteria:~* Patients must have taken trial medication during the 24-month trial period of GAL-INT-8
and should be enrolled within 1 month after completion~* Patients and their primary caregiver give informed
consent for the participation in the trial~* Patients must have remained in good health, as determined by
medical history, complete physical examination and laboratory tests~
